AHA To FDA: Seek Suppliers In Non-Hurricane-Prone Areas, Ease Compounding Limits During Shortages

November 7, 2017 at 2:49 PM
In the wake of hurricane-caused drug shortages, the American Hospital Association is calling on FDA to push manufacturers of small-volume parenteral solutions to invest in ways to prevent future shortages, including moving firms to areas not prone to natural disasters. The hospital trade group also wants FDA to loosen compounding restrictions in the event of shortage. Parenteral solutions were the first products FDA greenlighted for limited importation in the wake of manufacturing shortfalls due to hurricane damage in Puerto Rico...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.